Daily News Podcast

FDA approves sufentanil


 

The FDA approves sufentanil for managing pain in patients who are in certified medical health care settings. Also today, Crohn’s disease is tied to anal canal high-risk HPV vaccination. Also today, ultrasound denervation tops radiofrequecy ablation for resistant hypertension, and primary care needs pile up for patients with sickle cell disease.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Screening for intimate partner violence
MDedge Hematology and Oncology
Validation for SLE low-disease definition
MDedge Hematology and Oncology
Heather Yeo: Surgical Residency Attrition
MDedge Hematology and Oncology
AKI linked to later dementia
MDedge Hematology and Oncology
Part B scheme raises concerns
MDedge Hematology and Oncology
Palliative care update highlights role of nonspecialists
MDedge Hematology and Oncology
NSAID risk score validated for CV events
MDedge Hematology and Oncology
TENS improves fibromyalgia pain
MDedge Hematology and Oncology
Is it time to revise ASCVD cardiovascular risk threshold?
MDedge Hematology and Oncology
Samuel Shem: House of God
MDedge Hematology and Oncology